Fig. 2

Kaplan–Meier survival plots of event free survival for post-matched analyses. Post-matched analysis of aspirin versus sarpogrelate on NACE (A), efficacy endpoint (B), GI bleeding (C), and ICH (D). Matched, propensity score matched; NACE, net adverse clinical events; GI, gastrointestinal; ICH, intracranial hemorrhage.